A new 3D structure of a cancer-linked protein bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments. The protein—BRD4—plays a critical role in how cells read, copy and repair DNA and helps determine how different kinds of cells are made; it has been linked to many types of cancer and is considered a promising target for future therapies. The study, led by scientists at Penn State and published in the journal Molecular Cell, found that BRD4 can attach to DNA-packaging structures in cells even without a molecular signal long believed to be necessary for the interaction.
New Insights into Cancer-Linked Protein BRD4 Could Lead to Innovative Treatments
A study led by Penn State scientists reveals a new 3D structure of the cancer-linked protein BRD4, showing its unexpected binding to chromosomes without a previously thought necessary molecular signal. This discovery could lead to new cancer treatments, which is significant for Iran as it faces health challenges including cancer prevalence.
👥 Key Players
📰 What Happened
Scientists at Penn State have revealed a new 3D structure of the BRD4 protein, showing it can bind to chromosomes without a previously necessary molecular signal. This discovery could pave the way for new cancer treatments.
- BRD4 is linked to various types of cancer and plays a critical role in DNA processes.
- The study was published in the journal Molecular Cell.
💡 Why It Matters
📚 Background
BRD4 is a protein that regulates gene expression and has been implicated in cancer development. Understanding its structure and function is vital for developing targeted therapies.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%